Erik Spickard

9PUBLICATIONS
72CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Predictive and prognostic markersCancer diagnosis
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|Nov 04, 2026
Adjuvant mFOLFOXIRI after curative-intent resection of oligometastatic colorectal cancer: phase II FANTASTIC trial.

|Nov 02, 2026
Neoadjuvant botensilimab with or without balstilimab in pMMR and dMMR colon cancer: the phase 2 UNICORN trial.

|Aug 07, 2025
ctDNA Longitudinal Analysis during Total Neoadjuvant Therapy and Nonoperative Management for Locally Advanced Rectal Cancer: A Biomarker Study from the NOMINATE Trial.

Takashi Akiyoshi, Eiji Shinozaki, Yusuke Maeda

|Jul 24, 2025
Longitudinal circulating tumor DNA analysis during treatment of locally advanced resectable gastric or gastroesophageal junction adenocarcinoma: the PLAGAST prospective biomarker study.

Aziz Zaanan, Audrey Didelot, Chloé Broudin

|Apr 09, 2025
Trifluridine/Tipiracil and Oxaliplatin as Induction Chemotherapy in Resectable Esophageal and Gastroesophageal Junction Adenocarcinoma: A Phase II Study.

Sarbajit Mukherjee, Yu Fujiwara, Christos Fountzilas

|Mar 21, 2025
Circulating Tumor DNA Assessment to Predict Risk of Recurrence After Surgery in Patients With Locally Advanced Esophageal Squamous Cell Carcinoma: A Prospective Observational Study.

Shogo Takei, Daisuke Kotani, George Laliotis

Pageof 2

Frequent Collaborators

5 joint publications

Adham Jurdi

3 joint publications

Minetta C Liu

2 joint publications

Yara L Verschoor

2 joint publications

Joris van de Haar